Revogene
Real Time Nucleic Acid Amplification System. 510(k) K220480, from Meridian Bioscience, Inc. (Cincinnati, OH). Product code OOI, class 2.
As of Nov 20, 2026, K220480 is an FDA 510(k) held by Meridian Bioscience, Inc., substantially equivalent on Jul 11, 2022 after 143 days, with no recalls tied to it in FDA's recall database.
- Review time: 143 days
- Recalls: 0
- Cited as a predicate by: 1 device
The Revogene® instrument is intended for in vitro diagnostic (IVD) use in performing nucleic acid testing of specific IVD assays in clinical laboratories. Revogene is capable of automated lysis and dilution of samples originating from various clinical specimen types. Revogene performs automated amplification and detection of target nucleic acid sequences by fluorescence-based real-time PCR.
- revogeneK170558 · Genepoc, Inc. · May 25, 2017
- RevogeneK222779 · Meridian Bioscience, Inc. · Jan 26, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 18, 2022
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.2570
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files